Fig. 1From: The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumoursSLC7A5 protein expression in invasive breast cancer cores. a Negative immunohistochemical (IHC) expression. b Positive IHC expressionBack to article page